Market Size of Nephrology Stents And Catheters Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 7.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Nephrology Stents And Catheters Market Analysis
The nephrology stents and catheters market is valued at USD 1.44 billion in 2023 and is expected to reach USD 2.03 billion by the year 2028, registering a CAGR of 7.10% over the forecast period.
COVID-19 impacted the growth of the nephrology stents and catheter market. The lockdown measures imposed by the government to avoid the spread of coronavirus among the population resulted in the shutting down of patient visits in hospitals, clinics, and dialysis centers, which has impacted the lives of patients suffering from nephrology diseases. For instance, from an article published in Frontiers in Physiology in July 2021, it has been observed that the diagnosis of various kidney diseases was delayed during the COVID-19 pandemic as non-urgent tests and visits were postponed due to the closure of medical services during the lockdown. This has affected the histological examination for kidney diagnosis in the initial days of the pandemic, impacting the demand for nephrology stents and catheters during the pandemic. However, in later times of the pandemic, with the resumption of non-essential surgical procedures, the market has started to gain traction. It is expected to continue the upward trend over the forecast period.
The increasing incidence of nephrology disorders, rising geriatric population, and technological advancement in the material used for catheters and stents are the major drivers for the market. For instance, as per the data published by the Australian Institute of Health and Welfare in August 2022, it was observed that in Aboriginal and Torres Strait Islanders, 292 males and 677 females per 100,000 population had chronic kidney diseases in 2021, respectively. As per the same source, Indigenous Australians were 4.6 times more likely to be diagnosed with chronic kidney disease than their non-Indigenous counterparts. Thus, such instances indicate that the demand for surgeries is expected to increase, which may surge the demand for nephrology stents and catheters, thereby propelling the market growth.
The strong pipeline scenario related to nephrology stents and catheters drives market growth. For instance, according to the research journal published by the Medical Device Network in January 2022, pipeline nephrology and urology products in 2021 witnessed a 75.0% rise globally compared to Nephrology and Urology pipeline products in 2020. The devices at an advanced stage of development (in clinical trials, in the approval process, already approved in Europe, or in the rest of the world) accounted for 45.65% of medical devices in 2021, compared to 37.93% in 2020. The number of devices at the approval stage in 2021 increased by 100.0% compared to 2020. Furthermore, the same source also stated that approximately 43.0% of pipeline nephrology and urology devices in 2021 were expected to receive regulatory approval by the end of 2025. The top device category expected to receive regulatory approval by the end of 2025 was urinary catheters, with 6.0% of devices. Thus, owing to increasing regulatory approvals, the demand for nephrology stents and catheters is expected to increase; thereby, considerable market growth is expected over the forecast period.
However, discomfort and pain due to stents and catheters and the risk of infection due to unclean instruments will likely restrict the market growth over the forecast period.
Nephrology Stents And Catheters Industry Segmentation
As per the report's scope, the catheter is a thin tube made from medical-grade materials used to treat diseases or perform a surgical procedure. Renal artery stenting is a procedure to open the renal arteries when they have become blocked due to renal artery stenosis using nephrology stents. The Nephrology Stents and Catheters Market is Segmented by Product (Nephrology Catheters and Nephrology Stents), End-User (Hospital, Ambulatory Surgery Centers, and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Product | ||||||
| ||||||
|
| By End-User | |
| Hospitals | |
| Ambulatory Surgical Centers | |
| Specialty Clinics |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Nephrology Stents And Catheters Market Size Summary
The nephrology stents and catheters market is poised for significant growth, driven by an increasing incidence of nephrology disorders, a rising geriatric population, and advancements in catheter and stent technology. The market experienced a temporary setback due to the COVID-19 pandemic, which led to delayed diagnoses and postponed medical services, impacting demand. However, as non-essential surgical procedures resumed, the market began to recover and is expected to continue its upward trajectory. The strong pipeline of nephrology and urology products, along with regulatory approvals, is anticipated to further propel market growth. Despite challenges such as discomfort and infection risks associated with stents and catheters, the market is supported by the advantages of balloon catheters and the growing prevalence of chronic kidney disease (CKD), particularly among older populations.
North America is expected to hold a significant share of the nephrology stents and catheters market, driven by the high prevalence of CKD, a well-established healthcare infrastructure, and advanced diagnostic tests. The United States, in particular, is witnessing growth due to key product launches, a high concentration of market players, and substantial healthcare expenditure. The market is moderately fragmented, with several global and regional companies competing for market share. Recent product launches and regulatory developments, such as the introduction of reusable catheters and recalls of certain dialysis catheters, highlight the dynamic nature of the market. Overall, the nephrology stents and catheters market is expected to experience considerable growth over the forecast period, supported by technological advancements and increasing awareness and diagnosis of kidney diseases.
Nephrology Stents And Catheters Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Incidence of Nephrology Disorders
-
1.2.2 Increasing Geriatric Population
-
1.2.3 Technological Advancement in the Material Used for Catheters and Stents
-
-
1.3 Market Restraints
-
1.3.1 Discomfort and Pain due to Stents and Catheters
-
1.3.2 Risk of Infection due to Unclean Instruments
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Buyers/Consumers
-
1.4.2 Bargaining Power of Suppliers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Product
-
2.1.1 Nephrology Catheters
-
2.1.1.1 Balloon Catheters
-
2.1.1.2 Malecot Catheters
-
2.1.1.3 J Tip Catheters
-
2.1.1.4 Pigtail Catheters
-
-
2.1.2 Nephrology Stents
-
2.1.2.1 Metal Stents
-
2.1.2.2 Polymer Stents
-
-
-
2.2 By End-User
-
2.2.1 Hospitals
-
2.2.2 Ambulatory Surgical Centers
-
2.2.3 Specialty Clinics
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Nephrology Stents And Catheters Market Size FAQs
What is the current Nephrology Stents and Catheters Market size?
The Nephrology Stents and Catheters Market is projected to register a CAGR of 7.10% during the forecast period (2024-2029)
Who are the key players in Nephrology Stents and Catheters Market?
AngioDynamics, Boston Scientific Corporation, Teleflex Incorporated, Cardinal Health Inc and Becton, Dickinson and Company are the major companies operating in the Nephrology Stents and Catheters Market.
